A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma

Clinical trial NCT07306299 · RECRUITING

Trial details

NCT number: NCT07306299
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma, High Grade

Start date: 2025-12-01
Primary completion: 2028-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.